127 related articles for article (PubMed ID: 36961178)
1. Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database.
Chen C; Huang X; Xu Y; Sun Q
Medicine (Baltimore); 2023 Mar; 102(12):e33326. PubMed ID: 36961178
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
Kim YJ; Kim K
Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
[TBL] [Abstract][Full Text] [Related]
3. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
[TBL] [Abstract][Full Text] [Related]
4. Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast.
Zhang H; Tang S; Biskup E; Zhang Y; Yong L; Chen L; Cai F
Technol Cancer Res Treat; 2022; 21():15330338221121086. PubMed ID: 36000314
[No Abstract] [Full Text] [Related]
5. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.
Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK
Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Malignant Phyllodes Tumors of the Breast: Characteristics and Outcomes Based on the Surveillance Epidemiology and End Results Database.
Xiao Y; Jiang Y; Xiong Y; Ruan S; Huang T
J Surg Res; 2020 May; 249():205-215. PubMed ID: 31991330
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast.
Park HJ; Ryu HS; Kim K; Shin KH; Han W; Noh DY
In Vivo; 2019; 33(1):263-269. PubMed ID: 30587634
[TBL] [Abstract][Full Text] [Related]
8. Effect of radiation therapy on patients with stage T3 or T4 malignant phyllodes tumors: a retrospective observational study based on SEER.
Zhang G; Yang P; Zeng J; Wei C
J Cancer Res Clin Oncol; 2023 Dec; 150(1):2. PubMed ID: 38153521
[TBL] [Abstract][Full Text] [Related]
9. Better survival was found in patients treated with breast-conserving surgery compared with mastectomy in malignant phyllodes tumor of the breast.
Chen CY; Ya-Chen
Updates Surg; 2024 Jan; 76(1):265-270. PubMed ID: 37289397
[TBL] [Abstract][Full Text] [Related]
10. Malignant phyllodes tumor of the breast: treatment and prognosis.
Mituś J; Reinfuss M; Mituś JW; Jakubowicz J; Blecharz P; Wysocki WM; Skotnicki P
Breast J; 2014; 20(6):639-44. PubMed ID: 25227987
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
12. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
[TBL] [Abstract][Full Text] [Related]
13. The implications of neighborhood socioeconomic status on surgical management and mortality in malignant phyllodes patients in the Surveillance, Epidemiology, and End Results program.
Obeng-Gyasi S; Bhattacharyya O; Li Y; Eskander M; Tsung A; Oppong B
Surgery; 2020 Dec; 168(6):1122-1127. PubMed ID: 32847674
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
[TBL] [Abstract][Full Text] [Related]
16. Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
Sun ZH; Chen C; Kuang XW; Song JL; Sun SR; Wang WX
Medicine (Baltimore); 2021 May; 100(18):e25880. PubMed ID: 33951002
[TBL] [Abstract][Full Text] [Related]
17. Management of phyllodes breast tumors.
Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
[TBL] [Abstract][Full Text] [Related]
18. Primary treatment of cystosarcoma phyllodes of the breast.
Chaney AW; Pollack A; McNeese MD; Zagars GK; Pisters PW; Pollock RE; Hunt KK
Cancer; 2000 Oct; 89(7):1502-11. PubMed ID: 11013364
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
[TBL] [Abstract][Full Text] [Related]
20. Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database.
Yang Z; Li K; Qiu P; Ma Y; Wang B; Yan Y; Meng D; Feng C; Ren Y; Li Y; Li P; Zhou C
Breast; 2021 Dec; 60():287-294. PubMed ID: 34844175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
